Reactive oxygen species alters the electrophysiological properties and raises [Ca2+]i in intracardiac ganglion neurons.
We have investigated the effects of the reactive oxygen species (ROS) donors hydrogen peroxide (H(2)O(2)) and tert-butyl hydroperoxide (t-BHP) on the intrinsic electrophysiological characteristics: ganglionic transmission and resting [Ca(2+)](i) in neonate and adult rat intracardiac ganglion (ICG) neurons. Intracellular recordings were made using sharp microelectrodes filled with either 0.5 M KCl or Oregon Green 488 BAPTA-1, allowing recording of electrical properties and measurement of [Ca(2+)](i). H(2)O(2) and t-BHP both hyperpolarized the resting membrane potential and reduced membrane resistance. In adult ICG neurons, the hyperpolarizing action of H(2)O(2) was reversed fully by Ba(2+) and partially by tetraethylammonium, muscarine, and linopirdine. H(2)O(2) and t-BHP reduced the action potential afterhyperpolarization (AHP) amplitude but had no impact on either overshoot or AHP duration. ROS donors evoked an increase in discharge adaptation to long depolarizing current pulses. H(2)O(2) blocked ganglionic transmission in most ICG neurons but did not alter nicotine-evoked depolarizations. By contrast, t-BHP had no significant action on ganglionic transmission. H(2)O(2) and t-BHP increased resting intracellular Ca(2+) levels to 1.6 ( +/- 0.6, n = 11, P < 0.01) and 1.6 ( +/- 0.3, n = 8, P < 0.001), respectively, of control value (1.0, approximately 60 nM). The ROS scavenger catalase prevented the actions of H(2)O(2), and this protection extended beyond the period of application. Superoxide dismutase partially shielded against the action of H(2)O(2), but this was limited to the period of application. These data demonstrate that ROS decreases the excitability and ganglionic transmission of ICG neurons, attenuating parasympathetic control of the heart.
Dyavanapalli
Jhansi
J
Division of Molecular Physiology, James Black Centre, College of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
Rimmer
Katrina
K
Harper
Alexander A
AA
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000814:Aniline Compounds; D000818:Animals; D000831:Animals, Newborn; D002118:Calcium / Q000502:physiology*; D055724:Electrophysiological Phenomena; D005260:Female; D005452:Fluoresceins; D005724:Ganglia; D006321:Heart; D006861:Hydrogen Peroxide / Q000494:pharmacology; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D008839:Microelectrodes; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D017382:Reactive Oxygen Species / Q000494:pharmacology*; D020122:tert-Butylhydroperoxide / Q000494:pharmacology
D000814:Aniline Compounds; D005452:Fluoresceins; C503942:Oregon green 488 BAPTA-1; D017382:Reactive Oxygen Species; D020122:tert-Butylhydroperoxide; D006861:Hydrogen Peroxide; D002118:Calcium
Circ Res. 1987 Apr;60(4):465-71
2885103
J Neurosci. 1997 Dec 1;17(23):9060-7
9364052
J Neurophysiol. 2006 Jun;95(6):3543-52
16611840
Annu Rev Physiol. 1996;58:299-327
8815797
Exp Physiol. 2003 May;88(3):315-27
12719756
Biochim Biophys Acta. 1989 Apr 14;980(2):175-80
2930785
Am J Physiol Regul Integr Comp Physiol. 2009 Jul;297(1):R52-9
19403861
Physiol Rev. 1999 Jul;79(3):917-1017
10390520
Neuron. 2006 Nov 22;52(4):649-61
17114049
Am J Physiol. 1998 Jul;275(1):C1-24
9688830
J Physiol. 1995 Jul 15;486 ( Pt 2):453-71
7473210
Am J Physiol. 1988 Oct;255(4 Pt 2):H789-800
3177670
Curr Opin Pharmacol. 2008 Apr;8(2):153-9
18243791
Cardiovasc Res. 2006 May 1;70(2):181-90
16580655
J Cardiovasc Pharmacol. 1998 Jun;31(6):937-44
9641480
Neuroscience. 2001;107(2):283-91
11731102
J Physiol. 2004 Nov 1;560(Pt 3):691-708
15331671
Eur J Pharmacol. 2008 Jun 10;587(1-3):267-72
18455720
Exp Physiol. 2009 Feb;94(2):201-12
18978036
J Comp Neurol. 2000 Sep 4;424(4):588-606
10931483
Am J Physiol. 1998 Oct;275(4):H1434-40
9746494
J Neurochem. 1996 May;66(5):2057-66
8780036
J Neurosci. 1997 Nov 15;17(22):8695-701
9348338
Biophys J. 2000 May;78(5):2655-67
10777761
J Neurochem. 2006 Sep;98(6):1789-97
16945102
J Mol Cell Cardiol. 1976 Feb;8(2):89-101
815555
Chem Biol Interact. 2008 Aug 11;174(3):163-76
18602625
Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):146-51
16445714
Brain Res. 1995 Jun 19;683(2):275-8
7552366
J Neurophysiol. 2001 Jun;85(6):2468-76
11387393
Am J Physiol Heart Circ Physiol. 2002 Dec;283(6):H2687-91
12388320
J Neurochem. 2006 Jun;97(6):1634-58
16805774
Auton Neurosci. 2009 Oct 5;150(1-2):45-52
19442588
J Neurophysiol. 2003 Sep;90(3):1956-64
12761283
J Neurophysiol. 2003 Jun;89(6):3039-50
12783949
Exp Physiol. 2009 Jan;94(1):46-53
18945757
Cardiovasc Res. 1999 Jan;41(1):41-54
10325952
J Physiol. 2003 Oct 1;552(Pt 1):283-93
12897166
Chem Biol Interact. 2009 Oct 30;181(3):366-76
19647727
J Neurosci. 2008 Feb 13;28(7):1733-44
18272694
J Neurophysiol. 1997 Oct;78(4):1890-902
9325358
J Mol Cell Cardiol. 1999 Jan;31(1):113-21
10072720
Eur J Neurosci. 2004 May;19(10):2693-702
15147303
Am J Physiol Gastrointest Liver Physiol. 2000 Nov;279(5):G893-902
11052985
Circ Res. 1994 May;74(5):895-903
8156636
EMBO J. 2006 Oct 18;25(20):4996-5004
17024175
Circulation. 1992 Jan;85(1 Suppl):I77-91
1728509
Eur J Pharmacol. 2009 Aug 1;615(1-3):40-9
19446543
J Neurophysiol. 2010 Jan;103(1):382-91
19906875
J Physiol. 2003 Jul 1;550(Pt 1):83-101
12879862